Literature DB >> 47194

Pharmocokinetics of heparin. Distribution and elimination.

J W Estes, P F Poulin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47194

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN: 0340-5338


× No keyword cloud information.
  7 in total

1.  Pharmacokinetic modeling of heparin and its clinical implications.

Authors:  T J McAvoy
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

Review 2.  Coagulative interventions during angiography.

Authors:  J J Bookstein; K M Moser; C Hougie
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

3.  Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins.

Authors:  Edward N Harris; Bruce A Baggenstoss; Paul H Weigel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

Review 4.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

5.  [Risk of lung embolism following preventive intravenous use of heparin in polytraumatized patients].

Authors:  U Bosch; H Reilmann; J Sturm; W J Kleemann; G Windus
Journal:  Langenbecks Arch Chir       Date:  1988

Review 6.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of heparin.

Authors:  J W Estes
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.